Abstract
Purpose
Idiopathic pulmonary fibrosis (IPF) produces symptoms and activity limitations that impair health-related quality of life (HRQOL). The Patient-Reported Outcomes Measurement Information System® (PROMIS®) includes measures of self-reported health and HRQOL for a range of conditions. This study evaluated the HRQOL of individuals with IPF using PROMIS measures and examined associations between HRQOL and key symptoms or supplemental oxygen need.
Methods
Individuals who reported being told by a doctor that they have IPF completed an online battery of measures at baseline and 7–10 days later (for test–retest reliability). Measures included a brief survey of demographic and health-related questions, the PROMIS-29 profile, the Modified Medical Research Council Dyspnea Scale (MMRC), PROMIS dyspnea severity short form, A Tool to Assess Quality of life in IPF (ATAQ-IPF) and one cough item from the Functional Assessment of Chronic Illness Therapy (FACIT).
Results
220 individuals were included in the final sample. Except for sleep disturbance, all PROMIS domain scores significantly (p < .01) differed by MMRC level. Supplemental oxygen users were more impaired than non-users in fatigue, physical function, and social role participation (p < 0.01). The test–retest reliability was acceptable to excellent (>0.7) for all scales, but was lower for sleep disturbance (0.64).
Conclusions
People with IPF report substantial deficits in HRQOL across a range of PROMIS domains, and deficits vary by dyspnea and cough severity. These deficits warrant monitoring in clinical practice and consideration when investigating new therapies. Further research is required to further evaluate the psychometric performance of the PROMIS-29 in IPF.
Similar content being viewed by others
References
Pérez ERF, Daniels CE, Schroeder DR et al (2010) Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest 137:129–137
Raghu G, Weycker D, Edelsberg J et al (2006) Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174:810–816
Raghu G, Chen S-Y, Yeh W-S et al (2014) Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11. Lancet Respir Med 2:566–572
Collard HR, Moore BB, Flaherty KR et al (2007) Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 176:636–643
Idiopathic Pulmonary Fibrosis (2000) Diagnosis and treatment. Am J Respir Crit Care Med 161:646–664
Raghu G, Collard HR, Egan JJ et al (2011) An Official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824
Olson AL, Swigris JJ (2012) Idiopathic pulmonary fibrosis: diagnosis and epidemiology. Clin Chest Med 33:41–50
Papiris SA, Manali ED, Kolilekas L et al (2010) Clinical review: idiopathic pulmonary fibrosis acute exacerbations—unravelling Ariadne’s thread. Crit Care 14:246
Swigris J, Stewart A, Gould M et al (2005) Patients’ perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes 3:61
Swigris J, Kuschner W, Jacobs S et al (2005) Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax 60:588–594
Rothrock NE, Hays RD, Spritzer K et al (2010) Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the patient-reported outcomes measurement information system (PROMIS). J Clin Epidemiol 63:1195–1204
Stenton C (2008) The MRC breathlessness scale. Occup Med 58:226–227
Nishiyama O, Taniguchi H, Kondoh Y et al (2010) A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur Respir J 36:1067–1072
Cella D, Riley W, Stone A et al (2010) he Patient Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol 63:1179–1194
Liu H, Cella D, Gershon R et al (2010) Representativeness of the patient-reported outcomes measurement information system internet panel. J Clin Epidemiol 63:1169–1178
Victorson DE, Anton S, Hamilton A et al (2009) A conceptual model of the experience of dyspnea and functional limitations in chronic obstructive pulmonary disease. Value Health 12:1018–1025
Choi SW, Victorson DE, Yount S et al (2011) Development of a conceptual framework and calibrated item banks to measure patient-reported dyspnea severity and related functional limitations. Value Health 14:291–306
Yount SE, Choi SW, Victorson D et al (2011) Brief, valid measures of dyspnea and related functional limitations in chronic obstructive pulmonary disease (COPD). Value Health 14:307–315
Webster K, Cella D, Yost K (2003) The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 1:79
Swigris JJ, Wilson SR, Green KE et al (2010) Development of the ATAQ-IPF: a tool to assess quality of life in IPF. Health Qual Life Outcomes 8:77
Schalet BD, Yu L, Dodds N et al. (accepted) Clinical validity of PROMIS depression, anxiety and anger across diverse clinical samples. J Clin Epidemiol
Cella D, Jensen SE, Christodoulou C et al. (accepted) Clinical validity of the PROMIS fatigue item bank across diverse clinical samples. J Clin Epidemiol
Buysse DJ, Krystal AD, Johnston K, et al. Sleep and health-related function in a clinical sample as measured by PROMIS (patient-reported outcomes measurement information system). In: 26th Annual Meeting of the Associated Professional Sleep Societies, Sleep 2012, vol 35, pp A133–A133
Lin F-J, Pickard A, Krishnan J et al (2014) Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short form. BMC Med Res Methodol 14:78
Hinchcliff M, Beaumont JL, Thavarajah K et al (2011) Validity of two new patient-reported outcome measures in systemic sclerosis: patient-reported outcomes measurement information system 29-item health profile and functional assessment of chronic illness therapy–dyspnea short form. Arthr Care Res 63:1620–1628
Acknowledgments
The study was funded by Biogen.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Shih-Yin Chen is an employee and shareholder of Biogen. David Van Brunt was an employee of Biogen when the study was conducted and is a shareholder. This manuscript relates to study of disease for which Biogen is developing treatment. However, this manuscript in no way addresses the effects, or lack thereof, of any specific compound in development. The Northwestern University investigators received payment for bona-fide services in the execution of the study, but otherwise have no conflicts of interest to declare.
Ethical Approval
The Northwestern University Institutional Review Board determined that the study qualified for Exemption under United States Department of Health and Human Services CFR 46.101(b).
Rights and permissions
About this article
Cite this article
Yount, S.E., Beaumont, J.L., Chen, SY. et al. Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis. Lung 194, 227–234 (2016). https://doi.org/10.1007/s00408-016-9850-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-016-9850-y